NCT02660346View on ClinicalTrials.gov

IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 15, 2017

Study Completion Date

January 30, 2018

Conditions
Bacteremia
Interventions
DRUG

Daptomycin

Control Arm Treatment if used as monotherapy. Study Arm Treatment if used in combination with ceftaroline.

DRUG

Vancomycin

Control Arm Treatment

DRUG

Ceftaroline

Study Arm Treatment

Trial Locations (2)

91942

Sharp Grossmont Hospital, La Mesa

92123

Sharp Memorial Hospital, San Diego

All Listed Sponsors
lead

Sharp HealthCare

OTHER

NCT02660346 - IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB | Biotech Hunter | Biotech Hunter